Fulfilling The Promise Of Advanced Therapies And A Noble Cause

The promise of cell and gene therapy (CGT) is no longer a distant dream—today, it’s changing lives by targeting the root causes of disease. Once considered untreatable, many conditions now have real, lasting solutions thanks to CGT innovation. However, as scientific progress accelerates, a pressing challenge arises: how can we ensure that these therapies are accessible to everyone who needs them, regardless of their geographical location or socioeconomic status?

This webinar brings together two organizations united by a shared goal—bridging the gap between cutting-edge science and patient access. Dr. Inder Verma Dropulić of Vector BioMed and Dr. Vikram Patel of Muni Seva Ashram will discuss how their unique collaboration is advancing affordable and scalable solutions to make CGT more accessible, particularly in underserved regions.

Key topics include new approaches to point-of-care manufacturing, strategies for reducing cost-to-cure, and how purpose-driven infrastructure can transform therapeutic delivery worldwide.

Listen in to discover how mission alignment, innovation, and equity are redefining the future of medicine, where access is not an afterthought, but a design principle.